| Code | 82216 | ||||||||||
| MA number | 14/0721/09-S | ||||||||||
| Product Form: | tbl flm 10x10 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 14 - BRONCHODILATANTIA, ANTIASTHMATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.11.2009 |
| Pediatric posology: | Yes |
| PIL: |
PIL_ASTMASAN 10 mg_06/2024.pdf
|
| SPC: |
SPC_ASTMASAN 10 mg_06/2024.pdf
|
| Safety feature | Yes |
| Data update: | 16.04.2018 |
